Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 369-377

  Tao, Yingqun ^a   Liang, Guobiao ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

Epidermal growth factor; Glioma; Meta analysis; Polymorphism

Indexed keywords

EPIDERMAL GROWTH FACTOR;

ALLELE; ARTICLE; CANCER RISK; CAUCASIAN; COMPUTER PROGRAM; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GLIOMA; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; PUBLISHING; SENSITIVITY ANALYSIS;

ALLELES; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; EPIDERMAL GROWTH FACTOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLIOMA; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84894475665     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1052-0     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108.
3. Kleihues P, Cavanee WK. Pathology and genetics of tumours of the nervous system. 2nd ed. Lyon: IARC; 2000.
4. Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma. J Clin Oncol. 2006;24:1273-80.
5. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates inpatients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998;88:1-10.
6. Normanno N, Bianco C, De Luca A, Salomon DS. The role of EGFrelated peptides in tumor growth. Front Biosci. 2001;6:D685-707.
7. Laurence DJ, Gusterson BA. The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol. 1990;11:229-61.
8. Fenstermaker RA, CiesielskiMJ. Deletion and tandemduplication of exons 2-7 in the epidermal growth factor receptor gene of a human malignant glioma. Oncogene. 2000;19:4542-8.
9. SauterG, Maeda T,WaldmanFM, Davis RL, Feuerstein BG. Patterns of epidermal growth factor receptor amplification in malignant gliomas. Am J Pathol. 1996;148:1047-53.
10. Shahbazi M, Pravica V, Nasreen N, Fakhoury H, Fryer AA, et al. Association between functional polymorphism in EGF gene and malignant melanoma. Lancet. 2002;359:397-401.
11. Bhowmick DA, Zhuang Z,Wait SD,Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res. 2004;64:1220-3.
12. XuW, Li Y,Wang X, Chen B, Liu S, et al. Association between EGF promoter polymorphisms and cancer risk: a meta-analysis. Med Oncol. 2010;27:1389-97.
13. Zhang YM, Cao C, Liang K. Genetic polymorphism of epidermal growth factor 61A.G and cancer risk: a meta-analysis. Cancer Epidemiol. 2010;34:150-6.
14. Xin X. Lei Xi, Jie Zeng, Qinhong Yao: A functional +61G/a polymorphism in epidermal growth factor is associated with glioma risk among Asians. PLoS One. 2012;7(7):e41470.
15. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, et al. Association between functional EGF+ 61 polymorphism and glioma risk. Clin Cancer Res. 2007;13:2621-6.
16. Vauleon E, Auger N, Benouaich-Amiel A, Laigle-Donadey F, Kaloshi G, Lejeune J, et al. The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma. Cancer Genet Cytogenet. 2007;172:33-7.
17. Pinto GR, Yoshioka FK, Clara CA, SantosMJ, Almeida JR, Burbano RR, et al. Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil. Int J Biol Markers. 2009;24:277-81.
18. Liu X, Li L, Chen X, Wang X, Mu L, Li Y, et al. No association between EGF +61 A/G polymorphism and increased risk of glioma. Int J Biol Markers. 2009;24:77-82.
19. Wang S, Zhao Y, Ruan Z, Chen H, FanW, Chen J, et al. Association between EGF +61 G/A and glioma risk in a Chinese population. BMC Cancer. 2010;10:221.
20. Bao G, Wang M, Guo S, Han Y, Xu G. Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population. J Int Med Res. 2010;38:1645-52.
21. Muthusamy KA, Lian LH, Vairavan N, Chua KH, Waran V. Genetic polymorphisms of EGF 5′-UTR and NAT2 857G/A associated with glioma in a case control study ofMalaysian patients. Genet Mol Res. 2012;11:2939-45.
22. Li Y, Zhao Y, Liu J, Liu P, Xu Y. A functional polymorphism in the epidermal growth factor gene is associated with risk for glioma in a Chinese population. Genet Test Mol Biomarkers. 2012;16:449-52.
23. da Silveira F, Lopes Bde A, da Fonseca CO, Quirico-Santos T, de Palmer Paixao IC, de Amorim LM. Analysis of EGF +61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy. J Cancer Res Clin Oncol. 2012;138:1347-54.
24. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumor necrosis factoralpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443-9.
25. Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol. 2000;183:145-54.
26. Shen H, Wang L, Spitz MR, Hong WK, Mao L, Wei Q. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002;62:4992-5.
27. Salomon DS, Brandt R, Ciardiello F, et al. Epidermal growth factorrelated peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183-232.
28. Jin G,Miao R, Deng Y, et al. Variant genotypes and haplotypes of the epidermal growth factor gene promoter are associated with a decreased risk of gastric cancer in a high-risk Chinese population. Cancer Sci. 2007;98:864-8.
29. Lanuti M, Liu G, Goodwin JM, et al. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res. 2008;14: 3216-22.
30. Lim YJ, Kim JW, Song JY, et al. Epidermal growth factor gene polymorphism is different between schizophrenia and lung cancer patients in Korean population. Neurosci Lett. 2005;374:157-60.
31. Kang HG, Choi JE, Lee WK, et al. +61A>G polymorphism in the EGF gene does not increase the risk of lung cancer. Respirology. 2007;12:902-5.
32. Vishnoi M, Pandey SN, Modi DR, et al. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1-509C>T gene polymorphisms with gallbladder cancer. Hum Immunol. 2008;69:360-7.
33. Spindler KL, Nielsen JN, Ornskov D, et al. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer. Acta Oncol. 2007;46:1113-7.
34. Kang S, Kim JW, Park NH, et al. Epidermal growth factor 61 A/G polymorphism and uterine cervical cancer. Int J Gynecol Cancer. 2007;17:492-6.